Imunon, Inc. Increase (Decrease) in Income Taxes Receivable
Imunon, Inc. (IMNN) reported Increase (Decrease) in Income Taxes Receivable of $0 for the 12-month period ending 2011-12-31, per its 10-K/A filed 2012-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxesReceivable · last filed 2013-03-18
- Imunon, Inc. increase (decrease) in income taxes receivable for the quarter ending 2011-12-31 was $0.00.
- Imunon, Inc. increase (decrease) in income taxes receivable for the quarter ending 2011-09-30 was $0.00.
- Imunon, Inc. increase (decrease) in income taxes receivable for the quarter ending 2010-12-31 was $0.00.
- Imunon, Inc. increase (decrease) in income taxes receivable for the quarter ending 2010-09-30 was -$1.61M.
- Imunon, Inc. increase (decrease) in income taxes receivable for fiscal 2011 was $0.00.
- Imunon, Inc. increase (decrease) in income taxes receivable for fiscal 2010 was -$806.25K.
| Period end | Increase (Decrease) in Income Taxes Receivable 3 month | Increase (Decrease) in Income Taxes Receivable 6 month | Increase (Decrease) in Income Taxes Receivable 9 month | Increase (Decrease) in Income Taxes Receivable 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-K/A · filed 2012-03-15 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $0.00 10-Q · filed 2011-11-10 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$1.61M derived: sum of 2 quarters · filed 2013-03-18 | -$806.25K 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$806.25K 10-Q · filed 2011-11-10 | ||
| 2010-06-30 | $806.25K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |